Physician
Fiorella, Russell
Fiorella, Russell was paid $17.31M by Medicaid between Jan 2018 and Dec 2024, across 233 billing codes. Its largest line is 87389, Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies — 17% of everything it billed.
33Billing provider infoFIORELLA, RUSSELL
CHICAGO, IL 60608
CHICAGO, IL 60608
33aNPI1437125580assigned 02/28/2006
33bProvider typeClinical Pathology/Laboratory Medicine Physician
28Total paid$17.31M
24GClaims2,660,240
24DCodes billed233
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Clinical Pathology/Laboratory Medicine Physician providers in Illinois
Rank by total paid#2 of 34
Median peer was paid$104K
This provider vs. median167×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 287,330 | $1.78M | |
| 2019 | 473,505 | $3.08M | |
| 2020 | 414,781 | $2.46M | |
| 2021 | 426,055 | $2.61M | |
| 2022 | 387,366 | $2.88M | |
| 2023 | 363,172 | $2.70M | |
| 2024incomplete | 308,031 | $1.80M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 17% | 57,800 | 53,504 | $2.97M |
| 80053 | Comprehensive metabolic panel | 7.6% | 258,791 | 167,301 | $1.32M |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 7.6% | 54,111 | 50,797 | $1.32M |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 6.7% | 50,797 | 47,548 | $1.17M |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 5.4% | 327,229 | 191,401 | $932K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 4.3% | 31,615 | 25,331 | $744K |
| 84443 | Thyroid stimulating hormone (TSH) | 3.0% | 63,611 | 58,129 | $513K |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 2.7% | 33,464 | 31,034 | $470K |
| 80048 | Basic metabolic panel (calcium, ionized) | 2.6% | 112,804 | 61,289 | $450K |
| 83735 | 2.4% | 126,807 | 41,296 | $418K | |
| 86803 | 1.8% | 37,628 | 34,841 | $307K | |
| 83880 | 1.6% | 27,305 | 21,101 | $272K |
221 more codes
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 1.5% | 35,788 | $253K |
| 84484 | 1.4% | 60,483 | $241K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 1.3% | 6,498 | $233K |
| 87040 | 1.3% | 19,260 | $218K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 1.3% | 6,167 | $217K |
| 87086 | Culture, bacterial; quantitative colony count, urine | 1.2% | 39,135 | $201K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | 1.1% | 5,136 | $191K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 1.1% | 1,148 | $186K |
| 83036 | Hemoglobin; glycosylated (A1C) | 1.0% | 57,185 | $177K |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | <1% | 7,396 | $164K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 6,699 | $160K |
| 84100 | <1% | 102,143 | $156K | |
| 85027 | <1% | 53,139 | $149K | |
| 82948 | <1% | 72,855 | $147K | |
| 81001 | <1% | 98,593 | $132K | |
| 82607 | <1% | 22,150 | $132K | |
| 80061 | Lipid panel | <1% | 42,822 | $114K |
| 83690 | <1% | 33,524 | $112K | |
| 85730 | <1% | 37,535 | $111K | |
| 83970 | <1% | 6,498 | $100K | |
| 84702 | <1% | 20,968 | $94K | |
| 83605 | <1% | 19,105 | $91K | |
| 87340 | <1% | 13,862 | $89K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 2,563 | $87K |
| 85610 | <1% | 45,653 | $87K | |
| 82728 | <1% | 22,085 | $86K | |
| 86850 | <1% | 30,319 | $83K | |
| 87186 | <1% | 12,688 | $83K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 1,772 | $83K |
| 80074 | <1% | 4,309 | $79K | |
| 86901 | <1% | 35,338 | $79K | |
| 82805 | <1% | 2,793 | $77K | |
| 84439 | <1% | 16,444 | $72K | |
| 82746 | <1% | 12,010 | $68K | |
| 86900 | <1% | 35,299 | $59K | |
| 83540 | <1% | 17,972 | $57K | |
| 80055 | <1% | 3,461 | $53K | |
| 82570 | <1% | 23,298 | $52K | |
| 88307 | <1% | 845 | $48K | |
| 86780 | <1% | 5,814 | $47K | |
| 86706 | <1% | 6,664 | $46K | |
| 86003 | <1% | 1,780 | $43K | |
| 87081 | <1% | 14,217 | $39K | |
| 86140 | <1% | 16,309 | $38K | |
| 84703 | <1% | 10,519 | $37K | |
| 82962 | <1% | 24,563 | $37K | |
| 86592 | <1% | 18,322 | $36K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 4,511 | $36K |
| 87634 | <1% | 1,322 | $34K | |
| 82550 | <1% | 15,672 | $34K | |
| 85379 | <1% | 8,727 | $33K | |
| 84153 | <1% | 5,046 | $31K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 1,296 | $31K |
| 87486 | <1% | 1,403 | $31K | |
| 82553 | <1% | 8,430 | $31K | |
| 82043 | <1% | 15,605 | $31K | |
| 87581 | <1% | 1,405 | $30K | |
| 87625 | <1% | 2,200 | $27K | |
| 86160 | <1% | 2,960 | $26K | |
| 80076 | <1% | 7,964 | $25K | |
| 80069 | <1% | 6,358 | $25K | |
| 81025 | <1% | 7,627 | $21K | |
| 86480 | <1% | 803 | $21K | |
| 84146 | <1% | 3,108 | $21K | |
| 85652 | <1% | 15,407 | $20K | |
| 87070 | <1% | 6,952 | $20K | |
| 80202 | <1% | 3,024 | $20K | |
| 83615 | <1% | 10,066 | $20K | |
| 87493 | <1% | 829 | $19K | |
| 82140 | <1% | 4,550 | $18K | |
| 83001 | <1% | 2,021 | $18K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 1,141 | $18K |
| 80164 | <1% | 3,956 | $18K | |
| 84403 | <1% | 1,336 | $17K | |
| 84481 | <1% | 3,241 | $16K | |
| 86705 | <1% | 2,111 | $16K | |
| 80185 | <1% | 2,414 | $16K | |
| 82077 | <1% | 1,402 | $15K | |
| 84550 | <1% | 10,921 | $15K | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 956 | $14K |
| 87510 | <1% | 1,092 | $14K | |
| 87480 | <1% | 1,072 | $13K | |
| 82747 | <1% | 1,997 | $13K | |
| 87088 | <1% | 2,227 | $13K | |
| 87338 | <1% | 1,383 | $13K | |
| 82247 | <1% | 6,401 | $12K | |
| 87077 | <1% | 6,231 | $12K | |
| 84156 | <1% | 11,938 | $12K | |
| 82950 | <1% | 4,934 | $11K | |
| 86880 | <1% | 3,750 | $11K | |
| 87522 | Neg quan hep c or qual rna | <1% | 442 | $11K |
| 87536 | <1% | 246 | $11K | |
| 87641 | <1% | 494 | $10K | |
| 82248 | <1% | 7,462 | $10K | |
| 87660 | <1% | 1,178 | $10K | |
| 82105 | <1% | 1,238 | $10K | |
| 85384 | <1% | 3,236 | $10K | |
| 83550 | <1% | 2,228 | $9K | |
| 85014 | <1% | 9,682 | $9K | |
| 85018 | <1% | 9,499 | $9K | |
| 85660 | <1% | 3,894 | $9K | |
| 86141 | <1% | 1,052 | $9K | |
| 84300 | <1% | 3,988 | $8K | |
| 82436 | <1% | 3,645 | $8K | |
| 87075 | <1% | 1,354 | $8K | |
| 86431 | <1% | 2,240 | $8K | |
| 84133 | <1% | 3,714 | $8K | |
| 85007 | <1% | 5,196 | $7K | |
| 83002 | <1% | 1,429 | $7K | |
| 82010 | <1% | 3,926 | $7K | |
| 83655 | <1% | 1,204 | $7K | |
| 87205 | <1% | 3,797 | $7K | |
| 83930 | <1% | 2,866 | $7K | |
| 85045 | <1% | 5,401 | $7K | |
| 82150 | <1% | 2,057 | $7K | |
| 88342 | <1% | 517 | $6K | |
| 83021 | <1% | 1,014 | $6K | |
| 86762 | <1% | 1,534 | $6K | |
| 87209 | <1% | 370 | $6K | |
| 82951 | <1% | 917 | $6K | |
| 82533 | <1% | 807 | $5K | |
| 88304 | <1% | 283 | $5K | |
| 86039 | <1% | 987 | $5K | |
| 86870 | <1% | 721 | $5K | |
| 84165 | <1% | 752 | $5K | |
| 82274 | <1% | 944 | $5K | |
| 83010 | <1% | 1,085 | $5K | |
| 84480 | <1% | 1,082 | $5K | |
| 88313 | <1% | 418 | $4K | |
| 86677 | <1% | 576 | $4K | |
| 89051 | <1% | 1,201 | $4K | |
| 86787 | <1% | 535 | $4K | |
| 86593 | <1% | 2,005 | $4K | |
| 82565 | <1% | 1,944 | $4K | |
| 84145 | <1% | 222 | $4K | |
| 83935 | <1% | 1,388 | $3K | |
| 86709 | <1% | 850 | $3K | |
| 87177 | <1% | 372 | $3K | |
| 83516 | <1% | 549 | $3K | |
| 86200 | <1% | 517 | $3K | |
| 84132 | <1% | 2,018 | $3K | |
| 83498 | <1% | 320 | $3K | |
| 80050 | General health panel | <1% | 493 | $2K |
| 82542 | <1% | 330 | $2K | |
| 82261 | <1% | 286 | $2K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 101 | $2K |
| 83520 | <1% | 351 | $2K | |
| 83789 | <1% | 292 | $2K | |
| 85060 | <1% | 181 | $2K | |
| 81220 | CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants | <1% | 75 | $2K |
| 86255 | <1% | 253 | $2K | |
| 84478 | <1% | 876 | $2K | |
| 84520 | <1% | 2,215 | $2K | |
| 82378 | <1% | 240 | $2K | |
| 86360 | <1% | 94 | $2K | |
| 82952 | <1% | 805 | $2K | |
| 83020 | <1% | 264 | $1K | |
| 87045 | <1% | 236 | $1K | |
| 87116 | <1% | 249 | $1K | |
| 87517 | <1% | 55 | $1K | |
| 87102 | <1% | 409 | $1K | |
| 82652 | <1% | 106 | $1K | |
| 84460 | <1% | 1,021 | $1K | |
| 86334 | <1% | 90 | $1K | |
| 82803 | <1% | 156 | $1K | |
| 82465 | <1% | 819 | $1K | |
| 86359 | <1% | 90 | $1K | |
| 86922 | <1% | 71 | $1K | |
| 82784 | <1% | 178 | $1K | |
| 80178 | <1% | 315 | $1K | |
| 82776 | <1% | 286 | $1K | |
| 82977 | <1% | 628 | $998.90 | |
| 82310 | <1% | 1,804 | $987.48 | |
| 84134 | <1% | 315 | $982.61 | |
| 87206 | <1% | 373 | $942.84 | |
| 82330 | <1% | 109 | $923.16 | |
| 86704 | <1% | 128 | $887.74 | |
| 87807 | <1% | 174 | $872.99 | |
| 84075 | <1% | 646 | $822.32 | |
| 82947 | <1% | 430 | $729.64 | |
| 85130 | <1% | 124 | $722.84 | |
| 84450 | <1% | 421 | $665.80 | |
| 87210 | <1% | 271 | $639.37 | |
| 86735 | <1% | 94 | $599.14 | |
| 84466 | <1% | 129 | $573.99 | |
| 85460 | <1% | 278 | $537.29 | |
| 84425 | <1% | 78 | $529.82 | |
| 87185 | <1% | 142 | $493.95 | |
| 85520 | <1% | 118 | $466.94 | |
| 87449 | <1% | 67 | $438.67 | |
| 84436 | <1% | 130 | $437.31 | |
| 86905 | <1% | 109 | $400.20 | |
| 86765 | <1% | 90 | $378.07 | |
| 86256 | <1% | 35 | $359.56 | |
| 84540 | <1% | 193 | $329.11 | |
| 86707 | <1% | 64 | $311.25 | |
| 86376 | <1% | 60 | $302.14 | |
| 80156 | <1% | 66 | $297.01 | |
| 84155 | <1% | 167 | $263.79 | |
| 84270 | <1% | 27 | $230.55 | |
| 85613 | <1% | 52 | $182.88 | |
| 81003 | <1% | 161 | $176.73 | |
| 87046 | <1% | 130 | $172.90 | |
| 83721 | <1% | 236 | $167.09 | |
| 87324 | <1% | 25 | $150.35 | |
| 86038 | <1% | 18 | $150.07 | |
| 80143 | <1% | 13 | $145.34 | |
| 80179 | <1% | 12 | $134.16 | |
| 82945 | <1% | 90 | $133.98 | |
| 87252 | <1% | 15 | $117.30 | |
| 87253 | <1% | 15 | $112.50 | |
| 80162 | <1% | 13 | $77.88 | |
| 80320 | <1% | 11,334 | $70.28 | |
| 82040 | <1% | 51 | $67.31 | |
| 86703 | <1% | 16 | $62.76 | |
| 86308 | <1% | 12 | $28.80 | |
| 84157 | <1% | 15 | $23.00 | |
| 87147 | <1% | 14 | $22.40 | |
| 85008 | <1% | 45 | $8.45 | |
| 86923 | 0% | 2,898 | $0.00 | |
| 80329 | 0% | 595 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.